AISF position paper on HCV in immunocompromised patients
- PMID: 30366813
- DOI: 10.1016/j.dld.2018.09.022
AISF position paper on HCV in immunocompromised patients
Abstract
This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.
Keywords: HCV; Immunocompromised patients; Organ transplant.
Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources